Mahmoud Abdelsalam

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer

Hossein Borghaei, Filippo de Marinis, Daphne W. Dumoulin et al. · Annals of Oncology · 2023 · 78 citations · Full text

Nivolumab Versus Docetaxel, Medicine, Pharmacology +7

Pre-transplant FDG-PET-based survival model in relapsed and refractory Hodgkin’s lymphoma: outcome after high-dose chemotherapy and auto-SCT

Saad Akhtar, A. Al-Sugair, Mohei Abouzied et al. · Bone Marrow Transplantation · 2013 · 50 citations

Refractory Hodgkin ’, Lymphoid Neoplasia, Transplantation +8

Phase 3 KEYNOTE-361 trial: Pembrolizumab (pembro) with or without chemotherapy versus chemotherapy alone in advanced urothelial cancer.

Thomas Powles, Juergen E. Gschwend, Yohann Loriot et al. · Journal of Clinical Oncology · 2017 · 47 citations

Cisplatin-ineligible Pts, Tps4590 Background, Urology +13

Effects of microstructure and alloy composition on hydroxyapatite precipitation on alkaline treated α/β titanium alloys

Mahmoud Abdelsalam, Shimaa El‐Hadad, Waleed Khalifa · Materials Science and Engineering C · 2019 · 29 citations

Materials Engineering, Materials Science, Synthetic Bone Substitute +8